Register or Sign in to Save this opportunity, or Send an Inquiry.
Anti-Inflammatory Agent Showing Excellent Early Promise in Eye Models for Uveitis
Formuli United Kingdom flag United Kingdom
Abstract ID:
Recently gaining patent approval, this product is for Uveitis and Irritable Bowel Syndrome.
Send an Inquiry
RE:
Participants
You

Considerable in-vitro data has been generated showing this product to have excellent potential as an anti-inflammatory agent.  The company have selected Uveitis as a target indication and have Irritable Bowel Syndrome as a follow-up.


Looking for partners to move into the clinic.


 

Type of Business Relationship Sought
Funding, joint-venture, out-licensing
FEATURED
Last Updated Aug 2016
Technology Type MECHANISM
Phase of Development PRECLINICAL
CORPORATION

Opportunity Contact


Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833